180 Life Sciences accelerates vesting of executive/director equity; extends CAO contract

FORUM MARKETS Inc

Board accelerated full vesting of June 2025 restricted shares and options for CEO (410k options, 167,576 shares) and CAO (25k options, 8,174 shares) effective July 11-12.
Director awards also accelerated: Ryan Smith (255k options, 102,181 shares), Stephen Shoemaker (165k options, 67,439 shares), Lawrence Steinman (110k options, 44,959 shares).
All accelerated awards subject to shareholder approval of 2025 Option Incentive Plan; options cannot be exercised until approved.
Consulting agreement with CAO Van Lent extended to Dec 31, 2025; termination fee raised from $10k to $25k.

item 5.02item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.